iLite® anti-mTNF-alpha ADCC Activity Set

Add to my product list

This product contains a packaged set of the three individual products, one vial of each:
iLite® ADCC Effector (V) Assay Ready Cells (BM5001), 
iLite® ADCC Target mTNF-alpha (+) Assay Ready Cells (BM5013) 
iLite® ADCC Target mTNF-alpha (-) Assay Ready Cells (BM5014)
All three products are genetically engineered human cells to be used for measuring the ADCC activity of anti-mTNF-alpha antibodies. For more information about the individual cell lines, please consult the specific Product Specifications on

Product code
Assay Ready Cells

The products included in the iLite® anti-mTNF-alpha ADCC Activity Set can be used together for the quantification ADCC activity of anti-mTNF-alpha antibodies. 

Antibody-dependent cell-mediated cytotoxicity (ADCC) is a mechanism whereby pathogenic cells are lysed by lymphocytes, most often Natural Killer (NK) cells. The mechanism involves binding of antibodies to surface antigens on the pathogen. Crosslinking of these antibodies to NK cells through the binding of the Fc-portion to Fc receptors on the NK cells leads to activation of the NK cell and formation of an immune synapse with the pathogenic cell. The NK cell releases cytotoxic granules containing granzymes and perforin into the synapse, leading to apoptosis of the targeted cell.

3 vials of iLite® Assay Ready Cells (>250 µL). For contents of the individual vials, please please consult the specific Product Specifications.